Discussing RA: Safety and vaccine immunogenicity of upadacitinib across immune-mediated diseases
The IMID Forum25 Sep 2025

Discussing RA: Safety and vaccine immunogenicity of upadacitinib across immune-mediated diseases

Join Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he highlights two papers: risk of MACE, VTE, and malignancies in patients with RA or UC treated with filgotinib and frequency of reporting of MACE, MI, and stroke between JAKis and anti-TNFα.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(415)

Author Interview: Professor Axel Finckh and Associate Professor Bente Glintborg, August 2026

Author Interview: Professor Axel Finckh and Associate Professor Bente Glintborg, August 2026

Join Professor Peter Nash from the Griffith University in Brisbane; Professor Axel Finckh, from the Division of Rheumatology, Geneva University Hospitals, Geneva, Switzerland; and Bente Glintborg, an ...

13 Aug 26min

Discussing RA: Advanced therapy outcomes in RA

Discussing RA: Advanced therapy outcomes in RA

Join Professor Iain McInnes and Doctor Philip Mease for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, they examine key findings from studies b...

30 Jul 27min

Author Interview: Professor Laura Coates, July 2026

Author Interview: Professor Laura Coates, July 2026

Join Professor Peter Nash from the Griffith University in Brisbane, and Laura Coates, Professor at the University of Oxford’s Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Scie...

22 Jul 26min

Discussing axSpA: Long-term safety and efficacy of bimekizumab and ixekizumab in r-axSpA

Discussing axSpA: Long-term safety and efficacy of bimekizumab and ixekizumab in r-axSpA

Join Dr Sofia Ramiro and Professor Atul Deodhar as they discuss the top publications in the world of axSpA. This month, the conversation covered the long-term safety and efficacy of bimekizumab and ix...

16 Jul 23min

Author Interview: Dr Murat Torgutalp, June 2026

Author Interview: Dr Murat Torgutalp, June 2026

Join Professor Peter Nash from the Griffith University in Brisbane, and Dr Murat Torgutalp, from the Charité – Universitätsmedizin in Berlin, as they discuss his recent paper ‘Frequency and characteri...

9 Jul 29min

Discussing RA: Infectious complications of RA treatments

Discussing RA: Infectious complications of RA treatments

Join Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he will review two recent studies by Etani et al. and George et ...

25 Jun 9min

Author Interview: Doctor Chung-Mao Kao, May 2026

Author Interview: Doctor Chung-Mao Kao, May 2026

Join Professor Peter Nash from the Griffith University in Brisbane, and Doctor Chung-Mao Kao from Taichung Veterans General Hospital, as they discuss the recent publication ‘Malignancy risk in patient...

23 Jun 13min

Discussing PsA: Personalising treatment targets – understanding clinically meaningful improvement

Discussing PsA: Personalising treatment targets – understanding clinically meaningful improvement

Join Professor Laura Coates and Professor Philip Mease as they discuss a recent publication examining minimal clinically important improvement thresholds in psoriatic arthritis. This month’s conversat...

18 Jun 13min

Populært innen Fakta

fastlegen
dine-penger-pengeradet
relasjonspodden-med-dora-thorhallsdottir-kjersti-idem
foreldreradet
treningspodden
jakt-og-fiskepodden
rss-orjasater
rss-kunsten-a-leve
rss-strid-de-norske-borgerkrigene
mikkels-paskenotter
tomprat-med-gunnar-tjomlid
sinnsyn
hverdagspsyken
rss-var-forste-kaffe
fryktlos
gravid-uke-for-uke
hagespiren-podcast
rss-impressions-2
smart-forklart
dopet